‌

US Patent 8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

Patent 8840865 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

‌

Molecular Insight Pharmaceuticals, Inc.

Current Assignee

‌

Molecular Insight Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8840865

Date of Patent

September 23, 2014

Patent Application Number

14041643

Date Filed

September 30, 2013

Patent Citations Received

‌

US Patent 12091693 PSMA binding ligand-linker conjugates and methods for using

‌

US Patent 11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer

‌

US Patent 11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer

Patent Primary Examiner

‌

Sun Jae Yoo

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API